BYU Researchers Testing Drugs to Pretreat PTSD: A Promising Breakthrough Study

by time news

BYU researchers explore potential drug treatment to prevent PTSD

PROVO — Researchers at BYU are testing the use of drugs that could help pretreat people at risk for post-traumatic stress disorder.

Neuroscience professor Jeff Edwards conducted a study where rodents received drugs and were put through a traumatic situation to see if the drugs helped the rodents’ stress levels. The results found there is a possibility of pretreating people for PTSD before the traumatic memories form.

There are currently drugs available for people to reduce PTSD by taking a pill promptly after a traumatic experience to soften the strong memories that can form. Edwards’ research explores the potential of blocking those memories from forming before the experience even happens.

“We were really curious about whether some of those drugs used to reverse PTSD could be given to people we know have high risks — such as first responders or people in the military — before they experience stress, to prevent some of the cellular-level brain changes that are damaging in PTSD,” Edwards said.

For the study, the researchers injected rats with propranolol and mifepristone, drugs commonly used to treat PTSD retroactively. The rats then went through traumatic, stress-inducing experiences.

Results showed that rats undergoing stress that were not pretreated with the drug experienced a 30-40% increase in long-term potentiation. Those that were treated with the drug before experiencing stress had the same levels of long-term potentiation as the rats in a control group that didn’t experience any stress.

“The drugs brought the brain back to normal levels, how it should be working in memory formation, eliminating some of those maladaptive memories that create overly strong recall,” Edwards said.

The study also discovered pretreated rats had normal stress receptors after experiencing trauma, while the stress receptors of the rats that didn’t receive treatment were 80% less functional.

Eric Winzenried, who worked on the project while an undergrad at BYU, said, “An ounce of prevention is worth a pound of cure. Preventative treatment strategies like this are often much more effective. Although our work is very preliminary and in rodents, it is a piece in the puzzle that we hope will lead to better treatments for the prevention of PTSD in high-risk individuals.”

Further testing will need to be completed on rats before any human trials are conducted, a press release from BYU said.

You may also like

Leave a Comment